NO20062149L - Bengamidderivater, fremgangsmater for fremstilling og anvendelse av dette for behandling av cancer - Google Patents

Bengamidderivater, fremgangsmater for fremstilling og anvendelse av dette for behandling av cancer

Info

Publication number
NO20062149L
NO20062149L NO20062149A NO20062149A NO20062149L NO 20062149 L NO20062149 L NO 20062149L NO 20062149 A NO20062149 A NO 20062149A NO 20062149 A NO20062149 A NO 20062149A NO 20062149 L NO20062149 L NO 20062149L
Authority
NO
Norway
Prior art keywords
cancer
preparation
treatment
derivatives
methods
Prior art date
Application number
NO20062149A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Kurz
Holger Hoffmann
Sabine Haag-Richter
Heiko Tietgen
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20062149L publication Critical patent/NO20062149L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20062149A 2003-10-24 2006-05-12 Bengamidderivater, fremgangsmater for fremstilling og anvendelse av dette for behandling av cancer NO20062149L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10349669A DE10349669B3 (de) 2003-10-24 2003-10-24 Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP2004/011244 WO2005044803A1 (de) 2003-10-24 2004-10-08 Bengamide-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krebserkrankungen

Publications (1)

Publication Number Publication Date
NO20062149L true NO20062149L (no) 2006-07-11

Family

ID=34484998

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062149A NO20062149L (no) 2003-10-24 2006-05-12 Bengamidderivater, fremgangsmater for fremstilling og anvendelse av dette for behandling av cancer

Country Status (30)

Country Link
EP (2) EP1680405B1 (zh)
JP (1) JP4769190B2 (zh)
KR (1) KR20060120044A (zh)
CN (2) CN101294173A (zh)
AR (1) AR046553A1 (zh)
AT (2) ATE477244T1 (zh)
AU (1) AU2004287561B2 (zh)
BR (1) BRPI0415529A (zh)
CA (1) CA2543003A1 (zh)
CL (1) CL2009000674A1 (zh)
CY (1) CY1110458T1 (zh)
DE (3) DE10349669B3 (zh)
DK (1) DK1680405T3 (zh)
ES (1) ES2320894T3 (zh)
HK (1) HK1098131A1 (zh)
HR (1) HRP20090187T1 (zh)
IL (1) IL174524A (zh)
MA (1) MA28213A1 (zh)
ME (1) MEP33108A (zh)
MX (1) MXPA06004084A (zh)
NO (1) NO20062149L (zh)
NZ (1) NZ546744A (zh)
PL (1) PL1680405T3 (zh)
PT (1) PT1680405E (zh)
RS (1) RS20060263A (zh)
RU (1) RU2357956C2 (zh)
SI (1) SI1680405T1 (zh)
UY (1) UY28574A1 (zh)
WO (1) WO2005044803A1 (zh)
ZA (1) ZA200602231B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878525B1 (fr) * 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2878528B1 (fr) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5140099A1 (es) * 1998-11-17 2002-03-22 Novartis Ag Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
ATE383341T1 (de) * 2000-05-11 2008-01-15 Novartis Pharma Gmbh Substituierte caprolactam carbonate und ether sowie deren verwendung als anti-tumor wirkstoffe
JP2004262793A (ja) * 2003-02-28 2004-09-24 Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai 化合物ｎ−９０１１、その製造法及び用途
AU2004263287B2 (en) * 2003-07-25 2009-02-12 Novartis Ag Substituted lactams and their use as anti-cancer agents

Also Published As

Publication number Publication date
RS20060263A (en) 2008-09-29
ATE420074T1 (de) 2009-01-15
CN100398520C (zh) 2008-07-02
ATE477244T1 (de) 2010-08-15
IL174524A (en) 2012-08-30
JP2007509084A (ja) 2007-04-12
CA2543003A1 (en) 2005-05-19
MA28213A1 (fr) 2006-10-02
RU2006117769A (ru) 2007-11-27
EP1873146B1 (de) 2010-08-11
WO2005044803A1 (de) 2005-05-19
UY28574A1 (es) 2005-05-31
DE502004011536D1 (de) 2010-09-23
SI1680405T1 (sl) 2009-06-30
MXPA06004084A (es) 2006-06-27
DK1680405T3 (da) 2009-05-04
EP1680405B1 (de) 2009-01-07
AR046553A1 (es) 2005-12-14
DE502004008837D1 (de) 2009-02-26
AU2004287561B2 (en) 2011-06-02
EP1680405A1 (de) 2006-07-19
PT1680405E (pt) 2009-03-31
EP1873146A3 (de) 2008-05-21
AU2004287561A1 (en) 2005-05-19
CY1110458T1 (el) 2015-04-29
JP4769190B2 (ja) 2011-09-07
BRPI0415529A (pt) 2006-12-26
CN101294173A (zh) 2008-10-29
ES2320894T3 (es) 2009-05-29
EP1873146A2 (de) 2008-01-02
HRP20090187T1 (en) 2009-05-31
PL1680405T3 (pl) 2009-06-30
CN1871217A (zh) 2006-11-29
ZA200602231B (en) 2007-06-27
NZ546744A (en) 2009-03-31
KR20060120044A (ko) 2006-11-24
MEP33108A (en) 2010-10-10
DE10349669B3 (de) 2005-05-25
RU2357956C2 (ru) 2009-06-10
IL174524A0 (en) 2006-08-01
CL2009000674A1 (es) 2009-08-07
HK1098131A1 (en) 2007-07-13

Similar Documents

Publication Publication Date Title
GEP20022653B (en) Processes and Intermediates for Preparing Anti-Cancer Compounds
AU2003202585A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
HK1067963A1 (en) Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
MXPA03012013A (es) Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor.
NO996108L (no) 9-oksinerytromycinderivater
AU6350699A (en) Chemical compounds
NO20013680L (no) Ketolidantibiotika
NO20016401L (no) Th2 differensieringsinhibitorer
PL354030A1 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
NO20062149L (no) Bengamidderivater, fremgangsmater for fremstilling og anvendelse av dette for behandling av cancer
YU40002A (sh) Antipikornavirusna jedinjenja i kompozicije, njihove farmaceutske upotrebe, i materijali za njihove sinteze
NO20055750L (no) Nye kjemiske forbindelser
HK1046902A1 (zh) 新型哌嗪基烷基硫代嘧啶衍生物，包含該衍生物的藥物組合物以及製備該活性物質的方法
DE60214740D1 (en) 3-substituierte 7-alkylidene-3-cephem-4-carbonsäuren als beta-lactamase inhibitoren
AU2003212769A1 (en) Piperidine derivatives useful as modulators of chemokine receptor activity
GB0113232D0 (en) Chemical process
WO2002046152A3 (de) Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben
GB9909229D0 (en) Enantiomers of mercapto lactones and processes for their synthesis
MXPA01010409A (es) Compuestos inhibidores de beta-lactamasa.
BG108151A (en) Caloporoside derivatives, methods for the production thereof and their use
NO20060922L (no) Ny fremgangsmate for syntesen av perindopril og dens farmasoytiske akseptable salter
IL141009A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof
MXPA03009723A (es) Procedimientos e intermediarios para preparar epoxidos substituidos de bencilo.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application